Annals of neurology, 2020-06, Vol.87 (6), p.794-797
2020
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- SARS‐CoV‐2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad
- Ist Teil von
- Annals of neurology, 2020-06, Vol.87 (6), p.794-797
- Ort / Verlag
- Hoboken, USA: John Wiley & Sons, Inc
- Erscheinungsjahr
- 2020
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0364-5134eISSN: 1531-8249DOI: 10.1002/ana.25770Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7273059
- Format
- –
- Schlagworte
- Betacoronavirus - drug effects, Betacoronavirus - immunology, Coronavirus Infections - drug therapy, Coronavirus Infections - immunology, COVID-19, Humans, Immunosuppressive Agents - adverse effects, Immunosuppressive Agents - therapeutic use, Multiple sclerosis, Multiple Sclerosis - drug therapy, Multiple Sclerosis - immunology, Pandemics, Pneumonia, Viral - drug therapy, Pneumonia, Viral - immunology, Practice Guidelines as Topic - standards, SARS Virus - drug effects, SARS Virus - immunology, SARS-CoV-2, Severe Acute Respiratory Syndrome - drug therapy, Severe Acute Respiratory Syndrome - immunology